Zacks Investment Research on MSN22h
CorMedix (CRMD) Q4 Earnings and Revenues Beat EstimatesCorMedix (CRMD) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.17 per share. This compares to loss of $0.26 per share a year ago. These figures are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback